nifedipine has been researched along with Age-Related Osteoporosis in 4 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nifedipine is one of the common calcium channel blockers (CCBs) for hypertension that induce peroxisome-proliferator-activated receptor γ coactivator 1-α, which is envisioned as a potential therapeutic target in bone disease." | 8.31 | Association between clinical use of nifedipine and the risk of osteoporosis: a nationwide retrospective cohort study. ( Chang, CM; Chen, YC; Chou, YC; Lin, MH; Lin, TK; Sun, CA; Wu, WT, 2023) |
| "Nifedipine is one of the common calcium channel blockers (CCBs) for hypertension that induce peroxisome-proliferator-activated receptor γ coactivator 1-α, which is envisioned as a potential therapeutic target in bone disease." | 4.31 | Association between clinical use of nifedipine and the risk of osteoporosis: a nationwide retrospective cohort study. ( Chang, CM; Chen, YC; Chou, YC; Lin, MH; Lin, TK; Sun, CA; Wu, WT, 2023) |
| "Clodronate, etidronate and pamidronate are bisphosphonates introduced in the treatment of hypercalcaemia and osteoporosis." | 3.70 | Accumulation of bisphosphonates in human artery and their effects on human and rat arterial function in vitro. ( Kalliovalkama, J; Kankaanranta, H; Lähteenmäki, T; Pörsti, I; Salenius, JP; Sisto, T; Wu, X; Ylitalo, P; Ylitalo, R, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CM | 1 |
| Chen, YC | 1 |
| Wu, WT | 1 |
| Lin, TK | 1 |
| Chou, YC | 1 |
| Lin, MH | 1 |
| Sun, CA | 1 |
| Dorkkam, N | 1 |
| Wongdee, K | 1 |
| Suntornsaratoon, P | 1 |
| Krishnamra, N | 1 |
| Charoenphandhu, N | 1 |
| Zofková, I | 1 |
| Kancheva, RL | 1 |
| Ylitalo, R | 1 |
| Kalliovalkama, J | 1 |
| Wu, X | 1 |
| Kankaanranta, H | 1 |
| Salenius, JP | 1 |
| Sisto, T | 1 |
| Lähteenmäki, T | 1 |
| Ylitalo, P | 1 |
| Pörsti, I | 1 |
4 other studies available for nifedipine and Age-Related Osteoporosis
| Article | Year |
|---|---|
Association between clinical use of nifedipine and the risk of osteoporosis: a nationwide retrospective cohort study.
Topics: Calcium Channel Blockers; Cohort Studies; Female; Humans; Hypertension; Male; Nifedipine; Osteoporos | 2023 |
Prolactin stimulates the L-type calcium channel-mediated transepithelial calcium transport in the duodenum of male rats.
Topics: Animals; Calcium; Calcium Channels, L-Type; Duodenum; Female; Hyperprolactinemia; Intestinal Mucosa; | 2013 |
The effect of nifedipine on serum parathyroid hormone and calcitonin in postmenopausal women.
Topics: Calcitonin; Calcium; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; M | 1995 |
Accumulation of bisphosphonates in human artery and their effects on human and rat arterial function in vitro.
Topics: Animals; Arteries; Calcium Channel Blockers; Clodronic Acid; Diphosphonates; Drug Synergism; Etidron | 1998 |